Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Chimiothérapie
Extract
Prospective, Multicenter, Randomized, Independent-Group, Open-Label Phase II Study to Investigate the Efficacy, Safety and Tolerability of 4 Regimen With 3 Doses of ZK 219477 (16 and 12 mg/m<sup>2</sup> Body Surface Area as 3-Hour Infusion or 22 mg/m<sup>2</sup> Body Surface Area as 30-Minute or 3-Hour Infusion) in Patients With Metastatic Breast Cancer.
Scientific Abstract
en cours d'intégration;